Clinical Scorecard: Incidence of Newly Diagnosed Diabetes Among Patients Hospitalized for Myocardial Infarction or Stroke: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Newly diagnosed diabetes (NDD) in patients hospitalized for acute myocardial infarction (MI) or stroke
Key Mechanisms
Diabetes diagnosis during index hospitalization using oral glucose tolerance test (OGTT), haemoglobin A1c (HbA1c), or both
Target Population
Adult patients hospitalized for acute MI or stroke without previously known diabetes
Care Setting
Hospital inpatient setting during acute MI or stroke admission
Key Highlights
Approximately 16.0% of patients with MI and 15.3% of patients with stroke receive a new diagnosis of diabetes during hospitalization.
The proportion of newly diagnosed diabetes has remained stable over the past 30 years.
Use of oral glucose tolerance test yields a higher detection rate of new diabetes compared to HbA1c alone.
Guideline-Based Recommendations
Diagnosis
Screen all eligible patients hospitalized for MI or stroke for diabetes to identify undiagnosed cases.
Consider using oral glucose tolerance test in addition to HbA1c to improve diabetes detection rates.
Management
Early identification of diabetes during hospitalization may enable timely intervention to reduce cardiovascular risk.
Monitor patients with newly diagnosed diabetes for cardiovascular disease recurrence and mortality risk.
Standardize diabetes screening protocols in hospitalized patients with MI or stroke.
Risks
Patients with newly diagnosed diabetes at the time of MI or stroke have higher risk of cardiovascular recurrence and death compared to those without diabetes.
Potential missed opportunities for early diabetes diagnosis and prevention of cardiovascular events if screening is inadequate.
Patient & Prescribing Data
Adults hospitalized for acute myocardial infarction or stroke without previously known diabetes
Identification of new diabetes cases during hospitalization highlights the need for improved screening and subsequent management to prevent recurrent cardiovascular events.
Clinical Best Practices
Implement routine diabetes screening for all patients admitted with MI or stroke.
Use standardized diagnostic criteria and testing methods, preferably including OGTT, to improve detection accuracy.
Recognize newly diagnosed diabetes as a significant risk factor for cardiovascular disease recurrence and mortality.
Integrate diabetes management into post-MI and post-stroke care pathways to optimize outcomes.
